Metoprolol, a drug widely used to treat cardiovascular disease, is beneficial when administered to COVID-19patients. This is the finding of a study by investigators at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), published today in the Journal of the American College of Cardiology (JACC).
A drug costing less than €2 a day helps in the treatment of severely ill COVID-19 patients
August 30, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022